JP2024546759A5 - - Google Patents
Info
- Publication number
- JP2024546759A5 JP2024546759A5 JP2024534465A JP2024534465A JP2024546759A5 JP 2024546759 A5 JP2024546759 A5 JP 2024546759A5 JP 2024534465 A JP2024534465 A JP 2024534465A JP 2024534465 A JP2024534465 A JP 2024534465A JP 2024546759 A5 JP2024546759 A5 JP 2024546759A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290256P | 2021-12-16 | 2021-12-16 | |
| US202163290259P | 2021-12-16 | 2021-12-16 | |
| US63/290,259 | 2021-12-16 | ||
| US63/290,256 | 2021-12-16 | ||
| US202263341443P | 2022-05-13 | 2022-05-13 | |
| US63/341,443 | 2022-05-13 | ||
| PCT/EP2022/086040 WO2023111128A1 (en) | 2021-12-16 | 2022-12-15 | Caninized antibodies to canine interleukin-31 receptor alpha ii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546759A JP2024546759A (ja) | 2024-12-26 |
| JP2024546759A5 true JP2024546759A5 (enExample) | 2025-12-19 |
Family
ID=84923386
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534474A Pending JP2024546763A (ja) | 2021-12-16 | 2022-12-15 | イヌインターロイキン－３１受容体アルファｉに対するイヌ化抗体 |
| JP2024534465A Pending JP2024546759A (ja) | 2021-12-16 | 2022-12-15 | イヌインターロイキン－３１受容体アルファｉｉに対するイヌ化抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534474A Pending JP2024546763A (ja) | 2021-12-16 | 2022-12-15 | イヌインターロイキン－３１受容体アルファｉに対するイヌ化抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20250340653A1 (enExample) |
| EP (2) | EP4448572A1 (enExample) |
| JP (2) | JP2024546763A (enExample) |
| AU (2) | AU2022409603A1 (enExample) |
| CA (2) | CA3239826A1 (enExample) |
| MX (2) | MX2024007090A (enExample) |
| WO (2) | WO2023111148A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| WO2025174998A1 (en) * | 2024-02-13 | 2025-08-21 | Invetx, Inc. | Anti-il-31ra antibodies and uses thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| EP0216846B2 (en) | 1985-04-01 | 1995-04-26 | Celltech Limited | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| GB9818110D0 (en) | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6096002A (en) | 1998-11-18 | 2000-08-01 | Bioject, Inc. | NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method |
| US7696222B2 (en) | 2005-08-12 | 2010-04-13 | Merck Frosst Canada Ltd | Indole derivatives as CRTH2 receptor antagonists |
| KR101335843B1 (ko) | 2008-08-20 | 2013-12-02 | 조에티스 엘엘씨 | 피롤로[2,3-ｄ]피리미딘 화합물 |
| WO2010031182A1 (en) | 2008-09-22 | 2010-03-25 | Merck Frosst Canada Ltd. | Indole derivatives as crth2 receptor antagonists |
| CA2736571A1 (en) | 2008-09-22 | 2010-03-25 | Merck Frosst Canada Ltd. | Azaindole derivatives as crth2 receptor antagonists |
| KR101445012B1 (ko) | 2009-12-17 | 2014-09-26 | 머크 샤프 앤드 돔 코포레이션 | Ｓｙｋ 억제제로서의 아미노피리미딘 |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| CN106029697B (zh) | 2013-12-20 | 2021-06-04 | 英特维特国际股份有限公司 | 具有经修饰的ch2-ch3序列的犬抗体 |
| US20200181258A1 (en) * | 2016-10-17 | 2020-06-11 | Vetoquinol Sa | Modified antibody constant region |
| JP7116063B2 (ja) | 2016-12-14 | 2022-08-09 | インターベット インターナショナル ベー． フェー． | 選択的ヤヌスキナーゼ阻害剤としてのアミノピラゾール類 |
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| JP7536294B2 (ja) * | 2018-12-05 | 2024-08-20 | 株式会社バイカ・セラピュティクス | 抗体のＦｃ領域改変体 |
| CN113544153B (zh) * | 2019-01-03 | 2024-12-10 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| CN110563844A (zh) * | 2019-09-04 | 2019-12-13 | 华中农业大学 | 一种抗犬白介素31受体的多克隆抗体及其应用 |
| MX2022007676A (es) * | 2019-12-20 | 2022-07-19 | Intervet Int Bv | Anticuerpos caninizados biespecificos para tratar dermatitis atopica. |
-
2022
- 2022-12-15 MX MX2024007090A patent/MX2024007090A/es unknown
- 2022-12-15 JP JP2024534474A patent/JP2024546763A/ja active Pending
- 2022-12-15 MX MX2024007089A patent/MX2024007089A/es unknown
- 2022-12-15 AU AU2022409603A patent/AU2022409603A1/en active Pending
- 2022-12-15 CA CA3239826A patent/CA3239826A1/en active Pending
- 2022-12-15 WO PCT/EP2022/086084 patent/WO2023111148A1/en not_active Ceased
- 2022-12-15 US US18/720,564 patent/US20250340653A1/en active Pending
- 2022-12-15 AU AU2022409610A patent/AU2022409610A1/en active Pending
- 2022-12-15 WO PCT/EP2022/086040 patent/WO2023111128A1/en not_active Ceased
- 2022-12-15 JP JP2024534465A patent/JP2024546759A/ja active Pending
- 2022-12-15 CA CA3239307A patent/CA3239307A1/en active Pending
- 2022-12-15 US US18/720,576 patent/US20250340654A1/en active Pending
- 2022-12-15 EP EP22840575.9A patent/EP4448572A1/en active Pending
- 2022-12-15 EP EP22840571.8A patent/EP4448571A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022191383A5 (enExample) | ||
| JP2022177090A5 (enExample) | ||
| JP2024026132A5 (enExample) | ||
| JP2021526022A5 (enExample) | ||
| JP2022523442A5 (enExample) | ||
| HRP20110187T1 (hr) | Multispecifične deimunizirane tvari koje vežu cd3 | |
| JP2023545182A5 (enExample) | ||
| JP2023545183A5 (enExample) | ||
| WO2022166802A1 (zh) | 抗人cd271的单克隆抗体及用途 | |
| TW201815825A (zh) | 經修飾之抗原結合fab片段及包含其之抗原結合分子 | |
| CN115461368A (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| JP2014508511A5 (enExample) | ||
| CN115397852B (zh) | 工程化抗il-2抗体 | |
| JP7533897B2 (ja) | 融合タンパク質およびその使用 | |
| JP2023093753A5 (enExample) | ||
| JP2024516699A5 (enExample) | ||
| JP2020505927A5 (enExample) | ||
| JP2024540148A5 (enExample) | ||
| JP2024546759A5 (enExample) | ||
| JP2016520595A5 (enExample) | ||
| JP2022545682A5 (enExample) | ||
| CN112574300A (zh) | 抗sar-cov-2全人源单克隆抗体及其制法与应用 | |
| JP2024528935A5 (enExample) | ||
| JP2024516098A5 (enExample) | ||
| JP2021512652A5 (enExample) |